Clinical Research

Harold Collard Appointed as Associate Vice Chancellor of Clinical Research

Harold Collard, MD
Harold Collard, MD

We are thrilled to announce that Harold "Hal" Collard, MD, has been appointed as Associate Vice Chancellor of Clinical Research (AVC-CR) effective February 1, 2019. Hal will also continue to lead the CTSI organization as director.

New Pilot Award Supports Research on the Prevention and Treatment of Opioid Use Disorders

As part of UCSF’s Spring 2019 RAP funding cycle, CTSI is offering a new pilot award (up to $40,000) to support research projects focused on the prevention and treatment of opioid disorders.

UCSF NCATS-Supported Researchers Find Exercise May Help Protect DNA

The 46 human chromosomes are shown in blue, with the telomeres appearing as white pinpoints. (National Cancer Institute Photo/Hesed Padilla-Nash and Thomas Ried)
The 46 human chromosomes are shown in blue, with the telomeres appearing as white pinpoints. (National Cancer Institute Photo/Hesed Padilla-Nash and Thomas Ried)

People who care for chronically ill family members are at high risk for stress and health problems.

Measuring Newborns’ Weight Loss With Electronic Health Records to Give Babies a Healthy Start

Story posted via UCSF.edu

Reducing the Need for Non-Preventive Healthcare Utilization in the First Month of Life

New Immunotherapy for Deadly Childhood Brain Cancer Targets Novel 'Neoantigen'

Note: CTSI supported study - former KL2 Scholar Sabine Mueller along with former Catalyst awardee Hideho Okada are leading the phase I clinical trial of this research.

UCSF Research Leads to a Clinical Trial of New Cancer Vaccine and Development of Cell Therapy Approaches

Children with an extremely deadly form of brain cancer might benefit from a new treatment that aims to direct an immune response against a mutant form of a protein found exclusively on cancer cells, according to a new study led by UC San Francisco researchers.

Gut Feeling for Probiotics Benefits May Be Overstated, UCSF Study Shows

Note: The study was supported by funding from the National Institutes of Health and the Clinical and Translational Science Institute at UCSF.

By Suzanne Leigh

The protective effects of probiotics against colds, tummy bugs and more serious conditions have been exalted – and contested. Now a new study headed by UC San Francisco researchers further fuels the probiotics debate by finding that there is no clear evidence that a supplement of the “friendly” bacteria strain of lactobacillus prevents eczema, a frequent precursor to asthma.

Dearth of Clinical Study Participants Leads UCSF to Launch New Trial Finder Tool

Studies Nationwide Struggle to Find People to Meet Enrollment Goals

A Slight Increase in Pediatric Cancer Risk Seen with Infant Phototherapy

Risk May Be Greater for Children Born with Down Syndrome

Annual Research Festival Draws on Innovation of UCSF Learners

Annual digital scientific poster presentations from UCSF students. Co-sponsored by Pathways to Discovery & CTSI.

Pages